Table 4.

Secondary CNV treatment outcomes with stable state in Group 1 & 2.

Outcomes	Patients (N = 30)	P-value
Anatomical outcome		0.01**
Stable state* after treatment and observation with regular follow-up, n (%)	22 (73.3)
Subretinal fluid or subretinal membrane stationary after treatment, n (%)	6 (20.0)
Follow-up loss, n (%)	2 (6.7)
Duration until CNV regression† (median) [range]	10.4 ± 16.5 (5.2) [1.2–75.8]
Visual outcome		0.002‡
LogMAR BCVA at diagnosis of CNV	0.54 ± 0.50
LogMAR BCVA at last visit	0.35 ± 0.65

Group 1: Patients with secondary CNV in eyes with previous CSC.

Group 2: Patients diagnosed with CNV in eyes with putative chronic CSC beforehand.

*Stable state = CNV regression state with no further treatment.

^†CNV regression = consolidation or complete disappearance of subretinal fluid in OCT images.

**Statistical analysis with Chi-square tests.

^‡Statistical analysis with Wilcoxon signed rank tests.